ScholarIQanswers from OpenAlex

Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD

PaperCitations, authors & open-access status

Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD have?

ScholarIQcitation count

Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD has 134 citations in the OpenAlex counts ScholarIQ stores.

When was Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD published?

ScholarIQyear

Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD has 2021 year in the ScholarIQ index.

What is the open-access status of Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD?

ScholarIQoa status

Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD has hybrid oa status in the ScholarIQ index.

What is the DOI of Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD?

ScholarIQdoi

The DOI for Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD is on the source record.

What is the PMID of Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD?

ScholarIQpmid

The PMID for Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD is on the source record.

What is the OpenAlex record for Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD?

ScholarIQopenalex

The OpenAlex for Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial